Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2. [electronic resource]
Producer: 20120224Description: 175-81 p. digitalISSN:- 1791-7530
- Adenocarcinoma -- drug therapy
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Neoplasms -- drug therapy
- Brain Neoplasms -- drug therapy
- Carcinoma, Large Cell -- diagnosis
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Lymphatic Metastasis
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Small Cell Lung Carcinoma -- drug therapy
- Survival Rate
- Treatment Outcome
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.